Timo Sturm, Jan Dertinger, M. Hagmann, M. Thiel, Verena Schneider-Lindner
{"title":"Central Venous Oxygen Saturation above 75% on Day Three of Septic Shock is Associated with Tripled Mortality","authors":"Timo Sturm, Jan Dertinger, M. Hagmann, M. Thiel, Verena Schneider-Lindner","doi":"10.4172/2332-0877.1000338","DOIUrl":null,"url":null,"abstract":"Background: Central venous oxygen saturation (ScvO2) is commonly used to identify global oxygen uptakedelivery mismatches. A level above 70% was the declared goal in early resuscitation of septic shock for over a decade. Recent evidence leads to doubts and levels higher than 80% may represent harmful conditions. This study ´s aim was to identify favourable ScvO2 levels in treatment of septic shock. \nMethods: Electronic data of patients suffering from septic shock who have been admitted to the surgical intensive care unit of a university hospital were analysed surveying a period of six years with focus on the association of ScvO2 levels with in-hospital mortality. \nResults: Data from 238 individuals were included. No difference was found comparing initially measured values of ScvO2 of survivors to non-survivors. Patients whose levels of ScvO2 never exceeded 70% (n=28) had a higher mortality rate (73.2% vs. 54.3%, p<0.05). On day three patients with values above 75% (n=32) had higher mortality rates (59.4% vs. 38.5%, p<0.05). A mortality rate of 100% was detected if ScvO2 levels exceeded 84% (n=6). \nConclusions: ScvO2 develops from a therapy guiding parameter to a prognostic marker. Reaching levels of at least 70% within the first 72 h of disease is favourable in regard to prognosis. Exceeding 75% after day two is associated with higher mortality. These findings require further confirmation. At this point it can be assumed that a varying, time-dependent ScvO2 approach might be required for clinical decision-making.","PeriodicalId":73792,"journal":{"name":"Journal of infectious disease and therapy","volume":"2017 1","pages":"1-7"},"PeriodicalIF":0.0000,"publicationDate":"2017-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4172/2332-0877.1000338","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of infectious disease and therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2332-0877.1000338","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Central venous oxygen saturation (ScvO2) is commonly used to identify global oxygen uptakedelivery mismatches. A level above 70% was the declared goal in early resuscitation of septic shock for over a decade. Recent evidence leads to doubts and levels higher than 80% may represent harmful conditions. This study ´s aim was to identify favourable ScvO2 levels in treatment of septic shock.
Methods: Electronic data of patients suffering from septic shock who have been admitted to the surgical intensive care unit of a university hospital were analysed surveying a period of six years with focus on the association of ScvO2 levels with in-hospital mortality.
Results: Data from 238 individuals were included. No difference was found comparing initially measured values of ScvO2 of survivors to non-survivors. Patients whose levels of ScvO2 never exceeded 70% (n=28) had a higher mortality rate (73.2% vs. 54.3%, p<0.05). On day three patients with values above 75% (n=32) had higher mortality rates (59.4% vs. 38.5%, p<0.05). A mortality rate of 100% was detected if ScvO2 levels exceeded 84% (n=6).
Conclusions: ScvO2 develops from a therapy guiding parameter to a prognostic marker. Reaching levels of at least 70% within the first 72 h of disease is favourable in regard to prognosis. Exceeding 75% after day two is associated with higher mortality. These findings require further confirmation. At this point it can be assumed that a varying, time-dependent ScvO2 approach might be required for clinical decision-making.
背景:中心静脉氧饱和度(ScvO2)通常用于识别整体氧摄取递送不匹配。十多年来,在脓毒性休克的早期复苏中,70%以上是公认的目标。最近的证据引起了怀疑,高于80%的水平可能代表有害状况。本研究的目的是确定治疗感染性休克的有利ScvO2水平。方法:对某大学附属医院外科重症监护病房收治的感染性休克患者6年的电子数据进行分析,重点分析ScvO2水平与住院死亡率的关系。结果:纳入238人的数据。比较幸存者和非幸存者的ScvO2初始测量值没有发现差异。ScvO2水平从未超过70%的患者(n=28)死亡率更高(73.2% vs. 54.3%, p<0.05)。第3天,值大于75%的患者(n=32)死亡率较高(59.4% vs. 38.5%, p<0.05)。如果ScvO2水平超过84%,则检测到100%的死亡率(n=6)。结论:ScvO2已从治疗指导参数发展为预后指标。在发病后72小时内达到至少70%的水平有利于预后。2天后超过75%与更高的死亡率相关。这些发现需要进一步证实。在这一点上,可以假设临床决策可能需要一种变化的、随时间变化的ScvO2方法。